ProCE Banner Activity

Practical Considerations for CELMoDs in NHL


Download this patient-friendly resource card to learn more about the practical clinical considerations for investigations of CELMoDs in patients with non-Hodgkin lymphoma.

Released: May 23, 2024

Expiration: May 22, 2025



Julio C. Chavez

Julio C. Chavez, MD, MS

Associate Member
Department of Malignant Hematology
ICE-T Clinical Research Medical Director for Hematologic Malignancies
H. Lee Moffitt Cancer Center and Research Institute
Associate Professor
University of South Florida
Tampa, Florida

Alan Skarbnik

Alan Skarbnik, MD

Director, Lymphoma and CLL Program
Director, Immune Effector Cell Therapeutics Program
Novant Health Cancer Institute
Charlotte, North Carolina

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb